{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:58:50Z","timestamp":1781654330511,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.gene.2022.146680","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T11:46:06Z","timestamp":1655725566000},"page":"146680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Silencing effects of FOXD1 inhibit metastatic potentials of the PCa via N-cadherin \u2013 Wnt\/\u03b2-catenin crosstalk"],"prefix":"10.1016","volume":"836","author":[{"given":"Cigdem","family":"Donmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Konac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41065-020-00151-z","article-title":"Microarray data analysis reveals gene expression changes in response to ionizing radiation in MCF7 human breast cancer cells","volume":"157","author":"Bai","year":"2020","journal-title":"Hereditas."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1096-9896(200001)190:1<15::AID-PATH489>3.0.CO;2-L","article-title":"Re-expression of E-cadherin, \u03b1-catenin and \u03b2-catenin, but not of \u03b3-catenin, in metastatic tissue from breast cancer patients","volume":"190","author":"Bukholm","year":"2000","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.gene.2022.146680_b0015","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/cncr.20518","article-title":"Up-regulation of Wnt-1 and \u03b2-catenin production in patients with advanced metastatic prostate carcinoma: Potential pathogenetic and prognostic implications","volume":"101","author":"Chen","year":"2004","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13578-021-00671-9","article-title":"FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2","volume":"11","author":"Chen","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.gene.2022.146680_b0025","doi-asserted-by":"crossref","unstructured":"Cheng P, Wang J, Waghmare I, Sartini S, Coviello V, Zhang Z, et al. FOXD1\u2013ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Res. 2016;76(24):7219-30. doi: 10.1158\/0008-5472.CAN-15-2860.","DOI":"10.1158\/0008-5472.CAN-15-2860"},{"issue":"4","key":"10.1016\/j.gene.2022.146680_b0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W","article-title":"Detection and analysis of \u03b2-catenin mutations in prostate cancer","volume":"45","author":"Chesire","year":"2000","journal-title":"Prostate."},{"issue":"2","key":"10.1016\/j.gene.2022.146680_b0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","article-title":"Molecular mechanisms and biological functions of siRNA","volume":"13","author":"Dana","year":"2017","journal-title":"Int J Biomed Sci."},{"issue":"2","key":"10.1016\/j.gene.2022.146680_b0040","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3892\/or.2017.5344","article-title":"Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells","volume":"37","author":"Gao","year":"2017","journal-title":"Oncol Rep."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/kisup.2014.6","article-title":"The FOXD1 lineage of kidney perivascular cells and myofibroblasts: functions and responses to injury","volume":"4","author":"Gomez","year":"2014","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.gene.2022.146680_b0050","series-title":"Advances in Prostate Cancer","author":"Hamilton","year":"2013"},{"key":"10.1016\/j.gene.2022.146680_b0055","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.biopha.2018.04.190","article-title":"Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer","volume":"103","author":"Han","year":"2018","journal-title":"Biomed Pharmacother."},{"issue":"5","key":"10.1016\/j.gene.2022.146680_b0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.gene.2022.146680_b0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1083\/jcb.148.4.779","article-title":"Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis","volume":"148","author":"Hazan","year":"2000","journal-title":"J Cell Biol."},{"key":"10.1016\/j.gene.2022.146680_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1196\/annals.1294.016","article-title":"Cadherin switch in tumor progression","volume":"1014","author":"Hazan","year":"2004","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10549-013-2415-3","article-title":"Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer","volume":"138","author":"Hollestelle","year":"2013","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-016-0295-4","article-title":"Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells","volume":"16","author":"Kang","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.gene.2022.146680_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.627379","article-title":"Metastatic spread in prostate cancer patients influencing radiotherapy response","volume":"10","author":"Klusa","year":"2021","journal-title":"Front Oncol."},{"issue":"14","key":"10.1016\/j.gene.2022.146680_b0090","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.3390\/cancers13143446","article-title":"Regulation of Wnt Signaling by FOX Transcription Factors in Cancer","volume":"13","author":"Koch","year":"2021","journal-title":"Cancers."},{"issue":"18","key":"10.1016\/j.gene.2022.146680_b0095","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1177\/1535370217728499","article-title":"Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-\u03b14 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?","volume":"242","author":"Konac","year":"2017","journal-title":"Exp Biol Med."},{"issue":"7","key":"10.1016\/j.gene.2022.146680_b0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrc3539","article-title":"Forkhead box proteins: tuning forks for transcriptional harmony","volume":"13","author":"Lam","year":"2013","journal-title":"Nat Rev Cancer."},{"issue":"6","key":"10.1016\/j.gene.2022.146680_b0105","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1159\/000495962","article-title":"FOXD1 promotes cell growth and metastasis by activation of vimentin in NSCLC","volume":"51","author":"Li","year":"2018","journal-title":"Cell Physiol Biochem."},{"issue":"4","key":"10.1016\/j.gene.2022.146680_b0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"10.1016\/j.gene.2022.146680_b0115","doi-asserted-by":"crossref","unstructured":"Lou Y, Preobrazhenska O, auf dem Keller U, Sutcliffe M, Barclay L, McDonald PC, et al. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Dev Dyn. 2008;237(10):2755-68. doi: 10.1002\/dvdy.21658.","DOI":"10.1002\/dvdy.21658"},{"key":"10.1016\/j.gene.2022.146680_b0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/bonekey.2013.64","article-title":"Cadherins and Wnt signalling: a functional link controlling bone formation","volume":"2","author":"Marie","year":"2013","journal-title":"Bonekey Rep."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0125","first-page":"1","article-title":"The Wnts","volume":"3","author":"Miller","year":"2002","journal-title":"Genome Biol."},{"issue":"44","key":"10.1016\/j.gene.2022.146680_b0130","doi-asserted-by":"crossref","first-page":"22189","DOI":"10.1073\/pnas.1906484116","article-title":"Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer","volume":"116","author":"Moparthi","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0135","first-page":"261","article-title":"FOXD1 expression is associated with poor prognosis in non-small cell lung cancer","volume":"35","author":"Nakayama","year":"2015","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.gene.2022.146680_b0140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1083\/jcb.147.3.631","article-title":"N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression","volume":"147","author":"Nieman","year":"1999","journal-title":"J Cell Biol."},{"issue":"6","key":"10.1016\/j.gene.2022.146680_b0145","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.gene.2022.146680_b0150","first-page":"1522","article-title":"FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1\/2 pathway","volume":"10","author":"Pan","year":"2018","journal-title":"Am J Transl Res."},{"issue":"3","key":"10.1016\/j.gene.2022.146680_b0155","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7150\/jca.47978","article-title":"Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma","volume":"12","author":"Qiu","year":"2021","journal-title":"J Cancer."},{"issue":"12","key":"10.1016\/j.gene.2022.146680_b0160","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/sj.bjc.6605991","article-title":"An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer","volume":"103","author":"Querzoli","year":"2010","journal-title":"Br J Cancer."},{"issue":"Pt 19","key":"10.1016\/j.gene.2022.146680_b0165","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1242\/jcs.02552","article-title":"Epithelial-mesenchymal transition","volume":"118","author":"Radisky","year":"2005","journal-title":"J Cell Sci."},{"issue":"6","key":"10.1016\/j.gene.2022.146680_b0170","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","article-title":"Epithelial-Mesenchymal Transition in Cancer: A Historical Overview","volume":"13","author":"Ribatti","year":"2020","journal-title":"Transl Oncol."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0175","first-page":"23","article-title":"E-cadherin's dark side: possible role in tumor progression","volume":"1826","author":"Rodriguez","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.gene.2022.146680_b0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2017.03.009","article-title":"Cellular determinants and microenvironmental regulation of prostate cancer metastasis","volume":"44","author":"Rycaj","year":"2017","journal-title":"Semin Cancer Biol."},{"issue":"18","key":"10.1016\/j.gene.2022.146680_b0185","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1128\/MCB.00694-14","article-title":"Cellular migration and invasion uncoupled: increased migration is not an inexorable consequence of epithelial-to-mesenchymal transition","volume":"34","author":"Schaeffer","year":"2014","journal-title":"Mol Cell Biol."},{"issue":"5","key":"10.1016\/j.gene.2022.146680_b0190","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1083\/jcb.201306088","article-title":"Twist1-induced dissemination preserves epithelial identity and requires E-cadherin","volume":"204","author":"Shamir","year":"2014","journal-title":"J Cell Biol."},{"key":"10.1016\/j.gene.2022.146680_b0195","doi-asserted-by":"crossref","first-page":"104120","DOI":"10.1016\/j.mvr.2020.104120","article-title":"LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p\/FOXD1\/VEGF-A axis","volume":"134","author":"Sun","year":"2021","journal-title":"Microvasc Res."},{"issue":"2","key":"10.1016\/j.gene.2022.146680_b0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcb.20983","article-title":"Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer","volume":"99","author":"Terry","year":"2006","journal-title":"J Cell Biochem."},{"issue":"6","key":"10.1016\/j.gene.2022.146680_b0205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer."},{"issue":"5","key":"10.1016\/j.gene.2022.146680_b0210","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell."},{"issue":"2","key":"10.1016\/j.gene.2022.146680_b0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell."},{"issue":"11","key":"10.1016\/j.gene.2022.146680_b0220","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1464-410X.2009.08351.x","article-title":"Gene expression of forkhead transcription factors in the normal and diseased human prostate","volume":"103","author":"van der Heul-Nieuwenhuijsen","year":"2009","journal-title":"BJU Int."},{"key":"10.1016\/j.gene.2022.146680_b0225","unstructured":"World Health Organization-Cancer Profiles. https:\/\/gco.iarc.fr\/. Accessed 23 November 2021."},{"key":"10.1016\/j.gene.2022.146680_b0230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12935-020-01366-w","article-title":"LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429\/FOXD1\/ERK pathway","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.gene.2022.146680_b0235","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/pros.20877","article-title":"Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration","volume":"69","author":"Yu","year":"2009","journal-title":"Prostate."},{"issue":"3","key":"10.1016\/j.gene.2022.146680_b0240","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ajco.13451","article-title":"LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p\/FOXD1","volume":"17","author":"Zhang","year":"2021","journal-title":"Asia Pac J Clin Oncol."},{"issue":"1","key":"10.1016\/j.gene.2022.146680_b0245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbrc.2014.11.064","article-title":"FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27","volume":"456","author":"Zhao","year":"2015","journal-title":"Biochem Biophys Res Commun."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111922004991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111922004991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:56:21Z","timestamp":1759856181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111922004991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":49,"alternative-id":["S0378111922004991"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2022.146680","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silencing effects of FOXD1 inhibit metastatic potentials of the PCa via N-cadherin \u2013 Wnt\/\u03b2-catenin crosstalk","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2022.146680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146680"}}